Results 1 to 10 of about 16,279,763 (246)

Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice. [PDF]

open access: yesPLoS ONE, 2021
BackgroundPemphigus vulgaris (PV) is a rare autoimmune blistering disease characterized by the development of autoantibodies targeting desmoglein (Dsg) 3, but also against Dsg1 in mucocutaneous disease.
Katharina Boch   +10 more
doaj   +8 more sources

Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? [PDF]

open access: yesCells, 2022
Pemphigus vulgaris is an autoimmune blistering disease of the epidermis, caused by autoantibodies against desmosomal proteins, mainly desmogleins 1 and 3, which induce an impairment of desmosomal adhesion and blister formation. Recent findings have shown
Anna Zakrzewicz   +10 more
doaj   +3 more sources

Desmoglein 3 contributes to tumorigenicity of pancreatic ductal adenocarcinoma through activating Src–FAK signaling [PDF]

open access: yesAnimal Cells and Systems, 2021
Desmogleins (DSGs), with the ability to link adjacent cells, have been shown to participate in the development of malignancy. DSG3 was up-regulated in various cancers, including lung, head and neck, and esophagus squamous cell carcinoma, which ...
Yimamumaimaitijiang Abula   +3 more
doaj   +3 more sources

A New Solid-Phase Immunosorbent for Selective Binding of Desmoglein 3 Autoantibodies in Patients with Pemphigus Vulgaris. [PDF]

open access: goldActa Naturae, 2020
Autoantibodies, immunoglobulins G (IgG) against the desmosomal proteins desmogleins 1 and 3, play a significant role in the pathogenesis of pemphigus vulgaris.
Abramova TV, Spilevaya MV, Kubanov AA.
europepmc   +4 more sources

Binding to the neonatal Fc receptor enhances the pathogenicity of anti-desmoglein-3 antibodies in keratinocytes [PDF]

open access: goldFrontiers in Immunology
The neonatal Fc receptor (FcRn) is important for numerous cellular processes that involve antibody recycling and trafficking. A major function of FcRn is IgG recycling and half-life prolongation, and FcRn blockade results in a reduction of autoantibodies
Anna Zakrzewicz   +6 more
doaj   +3 more sources

Desmoglein-3 autoantibodies in tissues of oral lichen planus patients and its correlation with disease severity: case-control study [PDF]

open access: goldBMC Oral Health
Background Due to the not fully understood exact pathogenesis of oral lichen planus, the patients receive symptomatic management, rather than a curative treatment.
Doaa Abdelwadood   +3 more
doaj   +3 more sources

Acantholysis may precede elevation of circulating anti‐desmoglein 3 antibody levels in pemphigus vulgaris presenting with desquamative gingivitis [PDF]

open access: yesClinical and Experimental Dental Research, 2019
Pemphigus vulgaris (PV) is an autoimmune, blistering disease that affects the mucosa and skin. The current theory favors the concept that anti‐desmoglein (Dsg) 3 autoimmunity is the only pathogenic event needed to induce acantholysis.
Hiroyasu Endo   +8 more
doaj   +3 more sources

T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen. [PDF]

open access: yesJ Dermatol, 2023
Pemphigus is a life‐threatening autoimmune bullous disease mediated by anti‐desmoglein IgG autoantibodies. Pemphigus is mainly classified into three subtypes: pemphigus vulgaris, pemphigus foliaceus, and paraneoplastic pemphigus.
Takahashi H, Iriki H, Asahina Y.
europepmc   +2 more sources

Detection of Desmoglein-3 Auto-Antibodies in Patients with Lichen Planus [PDF]

open access: yesEgyptian Journal of Medical Research, 2022
There is controversy about the role of auto anti-bodies against desmoglein 3 (Dsg 3) in the pathogenesis of lichen planus (LP). The goal of this study is to detect desmoglein-3 auto-antibodies in lichen planus patients comparted to normal control persons
Abd-El Aziz El-Rifaie   +3 more
doaj   +2 more sources

Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells. [PDF]

open access: yesMol Oncol, 2022
Alterations of the Hippo–YAP pathway are potential targets for oral squamous cell carcinoma (OSCC) therapy, but heterogeneity in this pathway could be responsible for therapeutic resistance.
Ahmad US, Parkinson EK, Wan H.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy